41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      AP1 Factor Inactivation in the Suprabasal Epidermis Causes Increased Epidermal Hyperproliferation and Hyperkeratosis but Reduced Carcinogen-Dependent Tumor Formation

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          AP1 (jun/fos) factors comprise a family of transcriptional regulators ( c-jun, junB, junD, c-fos, FosB, Fra-1 and Fra-2) that are key controllers of epidermal keratinocyte survival and differentiation, and are important drivers of cancer development. Understanding the role of these factors in epidermis is complicated by the fact that each member is expressed in defined cell layers during epidermal differentiation, and because AP1 factors regulate competing processes (i.e., proliferation, apoptosis and differentiation). We have proposed that AP1 factors function differently in basal versus suprabasal epidermis. To test this, we inactivated suprabasal AP1 factor function in mouse epidermis by targeted expression of dominant-negative c-jun (TAM67) which inactivates function of all AP1 factors. This produces increased basal keratinocyte proliferation, delayed differentiation, and extensive hyperkeratosis. These findings contrast with previous studies showing that basal layer AP1 factor inactivation does not perturb resting epidermis. It is interesting that in spite of extensive keratinocyte hyperproliferation, susceptibility to carcinogen-dependent tumor induction is markedly attenuated. These novel observations strongly suggest that AP1 factors have distinct roles in the basal versus suprabasal epidermis, confirm that AP1 factor function is required for normal terminal differentiation, and suggest that AP1 factors play a different role in normal epidermis versus in cancer progression.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          AP-1 function and regulation.

          AP-1 (activating protein-1) is a collective term referring to dimeric transcription factors composed of Jun, Fos or ATF (activating transcription factor) subunits that bind to a common DNA site, the AP-1-binding site. As the complexity of our knowledge of AP-1 factors has increased, our understanding of their physiological function has decreased. This trend, however, is beginning to be reversed due to the recent studies of gene-knockout mice and cell lines deficient in specific AP-1 components. Such studies suggest that different AP-1 factors may regulate different target genes and thus execute distinct biological functions. Also, the involvement of AP-1 factors in functions such as cell proliferation and survival has been made somewhat clearer as a result of such studies. In addition, there has been considerable progress in understanding some of the mechanisms and signaling pathways involved in the regulation of AP-1 activity. In addition to regulation by heterodimerization between Jun, Fos and ATF proteins, AP-1 activity is regulated through interactions with specific protein kinases and a variety of transcriptional coactivators.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The regulation of AP-1 activity by mitogen-activated protein kinases.

            M Karin (1995)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

              Psoriasis is a frequent, inflammatory disease of skin and joints with considerable morbidity. Here we report that in psoriatic lesions, epidermal keratinocytes have decreased expression of JunB, a gene localized in the psoriasis susceptibility region PSORS6. Likewise, inducible epidermal deletion of JunB and its functional companion c-Jun in adult mice leads (within two weeks) to a phenotype resembling the histological and molecular hallmarks of psoriasis, including arthritic lesions. In contrast to the skin phenotype, the development of arthritic lesions requires T and B cells and signalling through tumour necrosis factor receptor 1 (TNFR1). Prior to the disease onset, two chemotactic proteins (S100A8 and S100A9) previously mapped to the psoriasis susceptibility region PSORS4, are strongly induced in mutant keratinocytes in vivo and in vitro. We propose that the abrogation of JunB/activator protein 1 (AP-1) in keratinocytes triggers chemokine/cytokine expression, which recruits neutrophils and macrophages to the epidermis thereby contributing to the phenotypic changes observed in psoriasis. Thus, these data support the hypothesis that epidermal alterations are sufficient to initiate both skin lesions and arthritis in psoriasis.
                Bookmark

                Author and article information

                Journal
                8711562
                6325
                Oncogene
                Oncogene
                0950-9232
                1476-5594
                24 June 2010
                6 September 2010
                4 November 2010
                4 May 2011
                : 29
                : 44
                : 5873-5882
                Affiliations
                [1 ]Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201
                [2 ]Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland 21201
                [3 ]Department of Obstetrics and Genecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland 21201
                [4 ]Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland 21201
                [5 ]Department of Cell Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44106
                Author notes
                Correspondence: Richard L. Eckert, Ph.D., Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Rm 103, Baltimore, Maryland 21201, Ph: 410-706-3220, reckert@ 123456umaryland.edu or Ellen A. Rorke, Ph.D., Department of Microbiology and Immunology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, Maryland 21201, erorke@ 123456SOM.umaryland.edu
                Article
                nihpa214963
                10.1038/onc.2010.315
                2974027
                20818430
                47c1c530-d745-44f1-9a2f-3461e34db76c

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS
                Award ID: R01 AR049713-06 ||AR
                Funded by: National Institute of Arthritis and Musculoskeletal and Skin Diseases : NIAMS
                Award ID: R01 AR046494-11 ||AR
                Categories
                Article

                Oncology & Radiotherapy
                skin cancer,tam67,epidermis,c-jun,keratinocyte differentiation
                Oncology & Radiotherapy
                skin cancer, tam67, epidermis, c-jun, keratinocyte differentiation

                Comments

                Comment on this article